Form 8-K - Current report:
SEC Accession No. 0001104659-20-116611
Filing Date
2020-10-21
Accepted
2020-10-21 07:35:23
Documents
15
Period of Report
2020-10-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2033805d1_8k.htm   iXBRL 8-K 30124
2 EXHIBIT 99.1 tm2033805d1_ex99-1.htm EX-99.1 560945
7 GRAPHIC tm2033805d5_ex99-1img001.jpg GRAPHIC 10073
  Complete submission text file 0001104659-20-116611.txt   864670

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA abt-20201021.xsd EX-101.SCH 3545
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abt-20201021_def.xml EX-101.DEF 28691
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE abt-20201021_lab.xml EX-101.LAB 37875
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abt-20201021_pre.xml EX-101.PRE 26910
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2033805d1_8k_htm.xml XML 5466
Mailing Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500
Business Address 100 ABBOTT PARK ROAD ABBOTT PARK IL 60064-3500 2246676100
ABBOTT LABORATORIES (Filer) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-02189 | Film No.: 201249625
SIC: 2834 Pharmaceutical Preparations